798 related articles for article (PubMed ID: 15958123)
1. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
2. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
Willison HJ; Plomp JJ
Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
[TBL] [Abstract][Full Text] [Related]
3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
4. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
6. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
7. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome: update on immunobiology and treatment.
Kaida K; Kusunoki S
Expert Rev Neurother; 2009 Sep; 9(9):1307-19. PubMed ID: 19769446
[TBL] [Abstract][Full Text] [Related]
10. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
11. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside mimicry and peripheral nerve disease.
Yuki N
Muscle Nerve; 2007 Jun; 35(6):691-711. PubMed ID: 17373701
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides as targets for autoimmune injury to the nervous system.
Willison HJ
J Neurochem; 2007 Nov; 103 Suppl 1():143-9. PubMed ID: 17986149
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
16. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
17. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
[TBL] [Abstract][Full Text] [Related]
19. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
20. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
